Nilotinib EP Impurity D
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

641569-94-0Nilotinib EP Impurity D

● Auf Lager

Katalog-Nr.::VE006047
CAS-Nr.::641569-94-0
Summenformel::C17H14N4O2
Molare Masse::306.33

Zusätzliche Informationen zu CAS 641569-94-0

Parent drug

Nilotinib

IUPAC-Name

4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid

Pharmakopöe-Synonyme

N/A

Other Synonyms

Nilotinib Carboxylic Acid Impurity

SMILES

O=C(O)C1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1

InChI

InChI=1S/C17H14N4O2/c1-11-4-5-12(16(22)23)9-15(11)21-17-19-8-6-14(20-17)13-3-2-7-18-10-13/h2-10H,1H3,(H,22,23)(H,19,20,21)

Beschreibung

Nilotinib EP Impurity D, also known as Nilotinib Carboxylic Acid Impurity is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Nilotinib. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications. Also known as Nilotinib Carboxylic Acid Impurity, it is an impurity present in Nilotinib is a synthetic amino pyrimidine, a second-generation tyrosine kinase inhibitor used for the treatment of imatinib-resistant chronic myelogenous leukemia in the form of nilotinib hydrochloride monohydrate salt.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url